CRP is also considered an independent marker of non-alcoholic fatty liver disease (NAFLD); the monitoring of its plasma level allows assessing the reduction in severe inflammatory activity and steatosis in NAFLD patients after a significant weight loss19. This evidence concerns the gene CRP and metabolic dysfunction-associated steatotic liver disease.